Navigation Links
Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results
Date:8/5/2008

phone replay also will be archived on the ''Investor Relations'' section of the company's Web site at http://www.simcere.com for seven days following the earnings announcement.

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (NYSE:SCR, Simcere) is a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in the rapidly growing China market. In recent years, Simcere has been focusing its strategy on the development of first-to-market generic and innovative pharmaceuticals, and has introduced a first-to-market generic stroke management medication under the brand name Bicun and an innovative anti-cancer medication under the brand name Endu. Simcere currently manufactures and sells more than 50 pharmaceutical products including antibiotics, anti-cancer medication and stroke management medication and is the exclusive distributor of three additional pharmaceuticals that are marketed under its brand names. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, osteoporosis and infectious diseases and currently has more than 12 pipeline products. For more information about Simcere Pharmaceutical Group, please visit http://www.simcere.com .

Simcere Pharmaceutical Group

UNAUDITED CONSOLIDATED CONDENSED STATEMENTS OF INCOME

(Amounts expressed IN THOUSANDS, EXCEPT PER SHARE AND PER ADS DATA)


'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
2. Simcere Pharmaceutical Group Reports Third Quarter 2007 Results
3. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
4. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
5. Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.s Fourth Investor Tour of China
6. Simcere Pharmaceutical Group to Announce First Quarter 2008 Earnings on Tuesday, May 6, 2008
7. Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd.
8. Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
9. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Diversity Focus, a ... environments for all residents in the Creative Corridor region, ... Survey at a news conference on Thursday, May 23rd ... study, conducted in 2008. , The survey ... lead and support efforts that attract, nurture and retain ...
(Date:5/21/2013)... Healing Center announces their participation in the CannaCommunity Solutions ... including MedMar Healing Center, doctors, and clubs, are coming together ... raise food to help area kids who have been impacted ... , “We like being able to give back to ... of MedMar Healing Center. “Taking part in the food drive ...
(Date:5/21/2013)... 2013) A paper recently published in the ... physicians and scientists at the University of Colorado School ... for pulmonary fibrosis can be used to identify individuals ... looked at a fairly common variant of the gene ... the mucous produced by the bronchial tubes. While this ...
(Date:5/21/2013)... 2013) Research into genetic features of pulmonary fibrosis ... School of Medicine may lead to improved treatment of ... online by JAMA . , The study found ... some cases of pulmonary fibrosis, a chronic progressive disease ... result of the study, researchers may want to consider ...
(Date:5/21/2013)... agency for scientific and technological research So Paulo Research ... announced an investment estimated in US$ 680 million to ... a period of up to eleven years, subject to ... , Funding for the 17 RIDCs will come from ... support personnel, and infrastructure). Host institutions will participate in ...
Breaking Medicine News(10 mins):Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Research at the cutting edge of knowledge 2
... stress disorder (PTSD) can occur in civilians, too and ... new review article in the Journal of the American ... a type of anxiety disorder that occurs after a person ... 20 to 51 percent of patients with an orthopaedic injury. ...
... present, it can take up to a year before a ... are diffuse and are often mistaken for other diseases. However, ... whether someone has the disease or not", says Christer Wingren, ... The test can also determine how far the disease has ...
... Seven out of ten hospital nurses who took part in ... administer intramuscular injections - despite the potential risks of sciatic ... hip site recommended by the nursing literature. ... the Journal of Advanced Nursing , found that younger, ...
... News) -- People at risk for celiac disease ought to ... symptoms, a new study suggests. Celiac disease is a ... the person consumes gluten, a protein found in wheat, rye ... has grown rapidly in recent decades, but, according to the ...
... May 9 (HealthDay News) -- Some adults with attention-deficit/hyperactivity ... everyday situations, a combination that appears to run in ... Hospital study that included 83 participants -- 23 with ... (DESR), 33 with neither condition -- plus their siblings. ...
... children taken to hospital emergency departments (EDs) for a head ... parents, concerns. Yet true traumatic brain injury is uncommon. A ... head trauma, led by Children,s Hospital Boston and UC Davis, ... use of head CT by as much as half without ...
Cached Medicine News:Health News:Post-traumatic stress disorder common following significant orthopedic trauma 2Health News:Post-traumatic stress disorder common following significant orthopedic trauma 3Health News:New test could give SLE patients a more tolerable life 2Health News:Most nurses don't use recommended intramuscular injection site despite potential risks 2Health News:Most nurses don't use recommended intramuscular injection site despite potential risks 3Health News:More People May Benefit From Going Gluten-Free 2Health News:ADHD With Poor Emotional Control Seems to Run in Families 2Health News:Large study finds CT scans are frequently unnecessary after head injury in children 2Health News:Large study finds CT scans are frequently unnecessary after head injury in children 3
(Date:5/21/2013)... 21, 2013 Reportlinker.com announces that ... in its catalogue:   ... for Medical Devices in the US Market ... Changing Regulatory and Reimbursement Scenario ...   Summary ...
(Date:5/21/2013)... REDWOOD CITY, Calif. , May 21, ... ACRX ), a specialty pharmaceutical company ... innovative therapies for the treatment of acute ... demonstrating that in a placebo-controlled Phase 3 ... PCA (patient-controlled analgesia) System (NanoTab System), the ...
(Date:5/21/2013)... and HENDERSONVILLE, N.C. , May ... procurement program for home medical equipment is forcing ... Carolina to lay off employees or close ... of service and products received by Medicare beneficiaries, says ... defective and dangerous program, the Centers for Medicare ...
Breaking Medicine Technology:Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 2North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 3North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 4
... Pharmaceuticals, a leading provider of contract manufacturing services ... multi-year contract-manufacturing agreement with an undisclosed biotechnology company. ... of a sterile liquid product used in processing ... of JHP noted, “We look forward to serving ...
... Cosmetic dentist in Torrance , Dr. Robert Mondavi, DDS, ... provide a safe and comfortable visit for area patients. ... revolutionizing dental examinations. The digital x-ray systems are used ... dental problems at or below the gum line. Early ...
Cached Medicine Technology:JHP Pharmaceuticals Announces Multi-Year Contract Manufacturing Agreement 2Torrance Dentist, Dr. Robert Mondavi, Now Uses Digital X-Rays for Comfort and Safety of the Patients 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: